Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report

Mariona Riudavets; Caroline Caramella; Pauline Pradere; Charles Naltet; Cécile Le Pechoux; Julien Adam; Laurence Mabille; Etienne Rouleau; Benjamin Besse; David Planchard

doi:10.1016/j.cllc.2020.10.011

Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report

Mariona Riudavets, Caroline Caramella, Pauline Pradere, Charles Naltet, Cécile Le Pechoux, Julien Adam, Laurence Mabille, Etienne Rouleau, Benjamin Besse, David Planchard

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

5 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	e215-e219
journal	Clinical Lung Cancer
Volume	22
Numéro de publication	2
Les DOIs	https://doi.org/10.1016/j.cllc.2020.10.011
état	Publié - 1 mars 2021

Accès au document

10.1016/j.cllc.2020.10.011

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Riudavets, M., Caramella, C., Pradere, P., Naltet, C., Le Pechoux, C., Adam, J., Mabille, L., Rouleau, E., Besse, B., & Planchard, D. (2021). Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report. Clinical Lung Cancer, 22(2), e215-e219. https://doi.org/10.1016/j.cllc.2020.10.011

@article{dedc6769c32648f69fe9191cb0f4acd5,

title = "Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report",

keywords = "Immune-checkpoint inhibitors, NSCLC, Oncogenic drivers, Predictive biomarkers, RET rearrangement",

author = "Mariona Riudavets and Caroline Caramella and Pauline Pradere and Charles Naltet and {Le Pechoux}, C{\'e}cile and Julien Adam and Laurence Mabille and Etienne Rouleau and Benjamin Besse and David Planchard",

year = "2021",

month = mar,

day = "1",

doi = "10.1016/j.cllc.2020.10.011",

language = "English",

volume = "22",

pages = "e215--e219",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

number = "2",

}

Riudavets, M, Caramella, C, Pradere, P, Naltet, C, Le Pechoux, C, Adam, J, Mabille, L, Rouleau, E, Besse, B & Planchard, D 2021, 'Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report', Clinical Lung Cancer, VOL. 22, Numéro 2, p. e215-e219. https://doi.org/10.1016/j.cllc.2020.10.011

Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report. / Riudavets, Mariona; Caramella, Caroline; Pradere, Pauline et al.
Dans: Clinical Lung Cancer, Vol 22, Numéro 2, 01.03.2021, p. e215-e219.

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

TY - JOUR

T1 - Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy

T2 - A Case Report

AU - Riudavets, Mariona

AU - Caramella, Caroline

AU - Pradere, Pauline

AU - Naltet, Charles

AU - Le Pechoux, Cécile

AU - Adam, Julien

AU - Mabille, Laurence

AU - Rouleau, Etienne

AU - Besse, Benjamin

AU - Planchard, David

PY - 2021/3/1

Y1 - 2021/3/1

KW - Immune-checkpoint inhibitors

KW - NSCLC

KW - Oncogenic drivers

KW - Predictive biomarkers

KW - RET rearrangement

UR - http://www.scopus.com/inward/record.url?scp=85095945115&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2020.10.011

DO - 10.1016/j.cllc.2020.10.011

M3 - Article

C2 - 33187915

AN - SCOPUS:85095945115

SN - 1525-7304

VL - 22

SP - e215-e219

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 2

ER -